Send feedback

SET p.Glu261Asp

c.783A>T · rs878926618 · VCV3160563

Uncertain significance Multiple submitters
Classification
Uncertain significance
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 2 submitters
AlphaMissense
likely benign
0.0623 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.00701%, nfe)
Missense predictors
0/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
2
Inborn genetic diseases

Computational evidence

Protein change
AlphaMissense0.0623likely benign
REVEL0.094moderately benign-leaning
SaProtLLR -7.21tolerated
⇒ AlphaMissense, REVEL and SaProt all call this tolerated.
Splicing
SpliceAIΔ0.21donor gain · deltas
Constraint at this position
ConservationphyloP 1.3GERP 0.015, phastCons 1
Regional constrainto/e 0.70unconstrained · MANE · 756 bp · p 0.017 · regional, not allelic
Overall
CADD18.83PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

⚠ Isoform check: AlphaMissense numbered on a different transcript (AM E274D vs ClinVar E261D) — verify the residue.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00701% European (non-Finnish) · 79/1,126,798 alleles
Filtering AF 0.00572% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.0053%
Overall 0.00604% 93/1,538,648 alleles · very rare exomes 85/1,386,754 · genomes 8/151,894 · joint denominator
Ancestry group Frequency 1 in
Remaining individualsnot grpmax-eligible 0.0117% 8,531
European (non-Finnish)grpmax 0.00701% 14,263
South Asian 0.00583% 17,139
African / African-American 0.00274% 36,473

Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
SET
Protein
p.Glu261Asp
Coding
c.783A>T
MANE Select
NM_003011
dbSNP
rs878926618
Type
single nucleotide variant
Location
chr9:128694015 (GRCh38)
Gene constraint
LOEUF 0.167 · pLI 1.00 · ClinGen HI 3/3 (gnomAD)
Structure
AlphaFold pLDDT 78.62 · 3 PDB
Residue 274 UniProt numbering
a UniProt-annotated variant site (in mrd58); the 'disordered' region
Full SET gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/set-p-glu261asp (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown